Original ArticleA Population-based Study of Malignant Spinal Cord Compression in Ontario
Introduction
Malignant spinal cord compression (MSCC) is one of the most devastating complications of cancer, usually presenting with a history of progressive pain, paralysis, sensory loss, and loss of sphincter control 1, 2. Since Spiller's first report of rapidly developing paraplegia associated with carcinoma in 1925 [1], numerous papers have described the management and outcome of MSCC in many different types of cancer 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16. However, a recent systematic review of the literature revealed no articles that describe either the incidence or the outcome of MSCC in the community at large [2]. Previous estimates of the incidence of MSCC have been based on the experience of individual institutions 15, 16, and are often confined to individual types of cancer 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13. The goal of this study was to describe the burden of MSCC at the population level. In the Canadian province of Ontario, we have linked electronic records from all hospitals and cancer centres to the province's population-based cancer registry. We have previously used this database to describe various aspects of the management and outcome of cancer in Ontario 17, 18, 19, 20, 21, 22, 23. We have now used this database to describe the incidence and the management of MSCC in the cancer population at large.
Section snippets
Sources of Data
The Ontario Cancer Registry (OCR) is a population-based tumour registry, operated by Cancer Care Ontario 24, 25. The OCR routinely receives electronic records of all admissions to hospitals in Ontario in which a diagnosis of cancer is recorded; electronic reports of cancer cases registered at any of the provincial cancer centres; electronic reports of all cancer-related deaths of Ontario residents from the office of the Registrar General of Ontario; and paper reports from all pathology
Incidence of MSCC
We identified a total of 3458 patients with cancer who had at least one admission for MSCC between January 1990 and December 1995. About 57% were men. The patients' median age at the time of the first episode of MSCC was 62 years (64 years for men and 58 years for women). Lung, prostate, and breast cancer accounted for 61.2% of the cases.
In the 6-year study period, 258 069 cases of cancer were diagnosed in Ontario. Of these, only 0.23% had MSCC at the time of diagnosis, or within 2 weeks
Discussion
This study provides a unique perspective on the problem of MSCC in a population of cancer patients, but it shares the weaknesses of other studies that rely primarily on administrative data; first, much clinically important information is simply unavailable and second, the completeness and accuracy of the available data is unknown 22, 31, 32, 33. Our results should be interpreted with those problems in mind.
Although MSCC emerges here as a common problem among patients dying of cancer, we have
Acknowledgments
This work was supported in part by grants from the National Cancer Institute of Canada, and Cancer Care Ontario (WJM). The authors gratefully acknowledge the help of Dr Eric Holowaty and the Ontario Cancer Registry in providing access to their data, and much helpful advice. Dr Loblaw undertook this project while he was a Resident in Radiation Oncology at Princess Margaret Hospital. He is now a Staff Radiation Oncologist at the Toronto-Sunnybrook Regional Cancer Centre, 2075 Bayview Avenue,
References (42)
- et al.
Characteristicsof spinal cord compression in adenocarcinoma of the prostate
Urology
(1986) - et al.
Spinal cord compression secondary to prostate carcinoma: treatment and prognosis
J Urol
(1993) - et al.
A population-based study of the effectiveness of breast conservation for newly diagnosed breast cancer
Int J Radiat Oncol Biol Phys
(2000) - et al.
A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer
Int J Radiat Oncol Biol Phys
(1999) - et al.
A population-based study of rectal cancer: Permanent colostomy as an outcome
Int J Radiat Oncol Biol Phys
(1999) - et al.
Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada
Int J Radiat Oncol Biol Phys
(1999) - et al.
An application of capture-recapture methods to the estimation of completeness of cancer registration
J Clin Epidemiol
(1988) - et al.
Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial
Int J Radiat Oncol Biol Phys
(1995) - et al.
Variations in the management and outcome of non-small cell lung cancer in Ontario
Radiother Oncol
(1994) - et al.
Rehabilitative functional outcome of patients with neoplasticspinal cord compression
Arch Phys Med Rehab
(1996)
Rapidly progressive paralysis associated with carcinoma
Arch Neurol Psychiatry
Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline
J Clin Oncol
Spinal cord compression in breast cancer: a review of 70 cases
Br J Cancer
Adenocarcinoma of the prostate and metastatic medullary compression
Scand J Urol Nephrol
Spinal cord compression in small-cell lung cancer: A retrospective review of 610 patients
Cancer
Metastatic spinal cord compression secondary to lung cancer
J Clin Oncol
Non-Hodgkin's Lymphoma presenting with spinal epidural involvement
Acta Oncol
Non-Hodgkin's Lymphoma presenting with spinal epidural involvement
Cancer
Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas
Cancer Treat Rep
CNS involvement in the non-Hodgkin's lymphoma
Cancer
Primary extranodal lymphoma
Cancer
Cited by (268)
Personalization of Radiation Therapy in the Primary Treatment of Malignant Epidural Spinal Cord Compression (MESCC)
2023, Seminars in Radiation OncologyStereotactic Body Radiation Therapy for Spinal Metastases: Benefits and Limitations
2023, Seminars in Radiation OncologyWhat Are the Signs, Symptoms, and Treatments of Spinal Cord Compression?
2023, Evidence-Based Practice of Palliative Medicine, Second EditionPalliative radiotherapy in the spine
2023, Palliative Radiation OncologyEpidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review
2022, Journal of Bone OncologyCitation Excerpt :The cumulative incidence of MESCC in patients with SM, ranges from 3.41% to 36.20% (mean 19.53%, 95% CI: -6.85%-45.91%) [15,19,22,24]. Mean cumulative incidence of MESCC in patients with breast, prostate or lung carcinoma is 1.47% (95% CI: 0.54%-2.40%) [15,16,24,43,28,29], 3.63% (95% CI: 1.47%-5.78%) [15,16,22,24,43,30–32,45–48], 2.80% (95% CI: 0.74%-4.86%) [15,16,22,24,43,34–36] respectively and mean cumulative incidence of MESCC in patients with SM of breast, prostate, or lung carcinoma is 8.26% (95% CI: 2.28%-14.24%), 11.49% (95% CI: -2.24%-25.23%) and 8.90% (95% CI: 0.65%-17.15%) respectively in the cohort studies. ( Fig. 2.